CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($) $ in Thousands	Total	IPO	Private Placement	Common Stock	Common Stock IPO	Common Stock Private Placement	Additional Paid‑In Capital	Additional Paid‑In Capital IPO	Additional Paid‑In Capital Private Placement	Accumulated Other Comprehensive Loss	Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2019				102,843,612
Beginning balance at Dec. 31, 2019	$ 500,722			$ 103			$ 568,756			$ 0	$ (68,137)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock (in shares)					13,500,000	85,880
Issuance of common stock		$ 322,413	$ 2,233		$ 14			$ 322,399	$ 2,233
Exercise of stock options (in shares)				526,460
Exercise of stock options	2,985						2,985
Vesting of restricted stock units (in shares)				36,520
Issuance of common stock under the employee stock purchase plan	0
Share‑based compensation	6,743						6,743
Foreign currency translation adjustment	0
Net loss	(24,082)										(24,082)
Ending balance (in shares) at Dec. 31, 2020				116,992,472
Ending balance at Dec. 31, 2020	811,014			$ 117			903,116			0	(92,219)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Exercise of stock options (in shares)				1,903,560
Exercise of stock options	10,691			$ 1			10,690
Vesting of restricted stock units (in shares)				530,032
Vesting of restricted stock units	1			$ 1
Issuance of common stock under the employee stock purchase plan	0
Share‑based compensation	35,805						35,805
Purchase of capped calls	(36,030)						(36,030)
Foreign currency translation adjustment	(7,866)									(7,866)
Net loss	(75,189)										(75,189)
Ending balance (in shares) at Dec. 31, 2021				119,426,064
Ending balance at Dec. 31, 2021	738,426			$ 119			913,581			(7,866)	(167,408)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Exercise of stock options (in shares)				842,188
Exercise of stock options	5,203			$ 1			5,202
Vesting of restricted stock units (in shares)				1,895,620
Vesting of restricted stock units	2			$ 2
Issuance of common stock under the employee stock purchase plan (in shares)				295,189
Issuance of common stock under the employee stock purchase plan	6,840						6,840
Issuance of common stock in connection with business combination (in shares)				711,111
Issuance of common stock in connection with business combination	15,083			$ 1			15,082
Share‑based compensation	109,170						109,170
Foreign currency translation adjustment	(32,085)									(32,085)
Net loss	(141,301)										(141,301)
Ending balance (in shares) at Dec. 31, 2022				123,170,172
Ending balance at Dec. 31, 2022	$ 701,338			$ 123			$ 1,049,875			$ (39,951)	$ (308,709)